Bulling brings extensive experience across the biopharma and CDMO landscape, with leadership roles spanning both drug substance and drug product operations
The work will leverage ProBioGen’s CHO.RiGHT expression platform, powered by its proprietary DirectedLuck transposase technology, alongside PsiBot smart automation
ProBioGen will oversee the design, construction, and operation of the 4,600-square-meter GMP manufacturing unit
This strategic move aims to address the increasing global demand for biologics, enhancing ProBioGen's ability to support partners from cell line development t
The AGE1.CR.pIX cell line's versatility allows it to support a wide range of viruses and vaccine types
Nous-209 has been developed using the Nouscom's viral vector platform
ProBioGen previously developed the cell line and the manufacturing process and provided the initial clinical material for ImmunOs' innovative biologic.
ProBioGen was able to carry on its rapid growth trajectory by completing a significantly increased number of projects.
Julian Collins, Jana Windt and Michiel Stork join biopharma company’s leadership team
The AGE1.CR.pIX cell line is derived from primary cells of a duck embryo and was designed to comply with health authority guidelines
Subscribe To Our Newsletter & Stay Updated
